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Research purpose: We have designed a prototype clinical workﬂow system that allows the speciﬁcation
and enactment of medical guidelines in terms of clinical goals to be achieved, maintained or avoided
depending on the patient’s disease and treatment evolution. The prototype includes: (1) an argumenta-
tion-based decision support system which can be used both to represent medical decisions within guide-
lines, and to dynamically choose the most suitable plans to achieve clinical goals, and (2) mechanisms to
specify a health organization’s facilities and health workers skills and roles, which can be taken into
account during the decision process in order to improve quality of care.
Results: The framework has been fully implemented in the COGENT formal modeling system. The proto-
type has been evaluated implementing a hypertension guideline.
Conclusions: The framework has shown ﬂexibility and adaptability in (1) advising and tailoring health
care based on a health organization’s resources and a patient’s particular medical condition, (2) delegat-
ing health care, and (3) replanning when unexpected situations arise.
Published by Elsevier Inc.1. Introduction
A gap between medical theory and practice is one of the most
consistent ﬁndings in health services research. Care procedures of-
ten differ signiﬁcantly between locations, yet it is known that pa-
tient outcomes are improved if standard ‘‘best practice’’ is
followed consistently. Computer-based decision-support systems
have been shown to be effective methods for improving adherence
to guidelines.
A number of process-based languages have been developed to
allow clinical guidelines to be expressed in well-deﬁned, com-
puter-interpretable formal languages to provide patient-speciﬁc
decision-support. According to Peleg et al. [1] review (including As-
bru [2], EON [3], GLIF [4], GUIDE [5], PRODIGY [6] and PROforma [7]
languages), the standard paradigm for modeling clinical processes
is based on ‘‘networks of tasks’’ in which tasks are modeled a steps
in a care process. Tasks can have a speciﬁc goal (for instance in
PROforma) or intention (as in Asbru). However, the need for clinical
guidelines to be adapted for use at different sites, to be tailored to
rapidly changing and unpredictable environments, and to be car-
ried out by distributed clinical teams, implies a degree of ﬂexibility
beyond that of current task-based guideline languages. Addition-
ally, personalization of clinical processes could potentially improve
the quality of care and reduce medical errors, but this is difﬁcult
using current systems.Inc.
.To address these problems we proposed in [8], instead of the
traditional task-based approach, a goal-based framework. We
interpreted goals as in both Fox et al. [9] seminal work on clinical
goals and Asbru language. Goals can be interpreted as temporal
patterns to be achieved, maintained or avoid. But while in both As-
bru and Fox et al. the patterns can refer to both provider actions
(monitor blood glucose once per week) and patient states (patient
has its glucose monitored once per week), for us clinical processes
are always state-based. Also inspired by Fox et al. work, in our
framework the goals of the guidelines are separated from detailed
plans to achieve those goals. When the guideline is applied to a
patient, ﬁrst the recommended goals for the intervention are
determined based on the clinical context, and then detailed activ-
ities are suggested to achieve those goals. This potentially allows
the same guideline to be applied at different sites, by different
types of clinical teams, and allows the guideline to adapt to the
needs of different patients and to unexpected circumstances.
In this paper we implement and evaluate a practical decision
support system (based on formal principles presented in [1]) that
suggests the best plans for achieving goals in this system. Our ini-
tial evaluation of the framework, based on the enactment of rec-
ommendations from three medical guidelines (hypertension [10],
NICE breast cancer guideline for breast cancer [11] and part of a
chronic cough guideline [12] corresponding to recommendations
for inmunocompetent adult patients), seems to show that the
goal-based framework provides ﬂexible mechanisms for the dis-
tributed enactment of clinical process and to address the problems
mentioned above.
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2 by explaining in detail our motivation, we continue in Section 3
with an explanation of the methods used. In Section 3.1 we explain
the goal-based framework that we introduced in [8] for the model-
ing of computer interpretable guidelines (CIGs). In Section 3.2 we
show how we further enhance the ﬂexibility of the framework
by introducing: (1) mechanisms to specify roles, necessary condi-
tions, and health workers skills in order to select the best health
provider for a care service, (2) speciﬁcations of the health organiza-
tion’s facilities and the patient’s medical record in order to adapt
and tailor the treatment on the ﬂy, and (3) an argumentation-
based decision support system which can be used to represent
medical decisions within guidelines, and to control the automatic
reﬁnement of plans as a guideline is carried out. We continue in
Section 4.1 explaining a prototype of the framework from Section
3.2 implemented in the COGENT modeling system (http://cogen-
t.psyc.bbk.ac.uk/). In Section 4.2 we explain how we encoded, in
the COGENT-based prototype, a guideline corresponding to the
treatment of high blood pressure [10]. The scenario presented in
Section 4.3 indicates that this framework can be used to enact care
paths that comply with national medical guidelines but are also
tailored to the patient’s treatment evolution maximizing the utility
based on the health organization’s facilities and the skills of the
health workers. Later in Section 5 we share some lessons learned
from evaluating three guidelines in the COGENT prototype pre-
sented here.
After comparing in Section 6 our approach with the current
state of the art we ﬁnish in Section 7 summarizing the main fea-
tures of the prototyped framework and our plans for its further
development into a more scalable language for the speciﬁcation
and enactment of CIGs.Fig. 1. State-based transition system for keystones in our proposed framework.2. Motivation
PROforma [7] was developed in the 1990s by Cancer Research
UK as an executable process modeling language. PROforma plans
have been successfully built and deployed in a broad range of deci-
sion support systems, guidelines and other clinical applications.
Besides being provided with a formal semantics based on state-
transition systems, PROforma has been used as the basis of aca-
demic and commercial decision support technologies: Tallis and
Arezzo.
PROforma, like most of the languages currently available for the
enactment of CIGs, provides a wholly centralized approach for the
enactment of medical applications.
According to [13]:’’Historically the responsibility for the detec-
tion and diagnosis of a patient condition and subsequent treatment
and follow-up were localized, in that the knowledge, actions and
responsibilities required for these duties were centered upon a
specialist team of professionals working in a particular physical
place. However, clinical practice is increasingly complex, distrib-
uted and service oriented’’. Nowadays actions are performed at
numerous specialist sites and responsibilities for care are often dis-
tributed and/or shared between care providers, obliging patients to
move between them to access services.
The challenge is to formally specify specialist services such as
decision support and workﬂow management, confederating such
systems without compromising the autonomy of each local service,
or the compliance to medical guidelines. In [14] strong arguments
are given to explain why the traditional wholly centralized ap-
proach for medical applications on which PROformawas based will
not scale well with the growing complexity of the medical con-
texts. On the other hand more recently service-oriented [14],
process-like [15] and multi-agent based systems [16,17] have been
proposed as viable approaches to develop fully distributedenactment environments. In particular in [14] a service-oriented
approach to distribute the enactment of PROforma plans was
proposed and evaluated in a cancer treatment scenario.
The purpose of this work is to contribute to the challenge by
proposing a novel approach (more comprehensive and ﬂexible
than [14]) for distributing the enactment of PROforma-like medical
guidelines between health providers with the aim of providing bet-
ter patient care. Our approach is based on: goal-based modeling of
CIGs as proposed in [8], shared repositories of speciﬁcations of ser-
vices offered by health providers, detailed descriptions of actors
and roles skills, and the use of a decision support system to advise
on the best service provider at run time. By modeling medical
applications at design time in terms of clinical outcomes it is pos-
sible to abstract from implementation details while providing
compliance to medical guidelines. At run time an argumentation-
based decision support system suggests the best way to pull to-
gether available resources to provide the best possible care for
the patient while adapting the guideline’s recommendations to
the realities of actual institutions and hospitals.
Belowwe explain in detail the formal semantics of the proposed
framework, as an extension of the goal-based formalism intro-
duced in [8].3. Methods
3.1. Framework for goal-based workﬂow enactment
What makes the framework presented in [8] different from tra-
ditional task-based approaches to model CIGs is the use of goals as
ﬁrst order objects, the automatic selection of tasks to achieve goals,
and replanning when goals fail or when goals are not achieved
even after enactment of a candidate task.
3.1.1. Workﬂow
A workﬂow is a network of nodes called keystones with unique
starting and ending points, connected by scheduling constraints.
3.1.2. Keystone
A keystone is an abstraction of tasks and goals. At run-time a
keystone is assigned a state. As is shown in Fig. 1, initially a key-
stone’s state is Dormant and it changes state to InProgress when
it is ready for enactment. The keystone only changes from InPro-
gress to Completed when the successCondition is satisﬁed. While
a keystone is InProgress it can be Discarded. If a keystone is Dis-
carded it needs to be reinitialized before it can be enacted. A key-
stone can be assigned a precondition, i.e. a predicate that must be
satisﬁed before the keystone becomes InProgress. A keystone can
be cyclic, in which case the cycleInterval indicates its frequency
of iteration. Time constraints can be attached to a keystone: startAt,
duration and ﬁnishAt, specifying the starting time, duration and
completion time for the keystone.
When a keystone is a goal and it is InProgress the goal’s
successCondition, abortCondition and invariantCondition (in case of
goals of type maintain) are monitored. If the successCondition is
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tion is satisﬁed or the invariantCondition is not satisﬁed then the
goal’s sate changes to Discarded. If the goal’s successCondition
and abortCondition are not satisﬁed a decision-support system pro-
poses candidatePlans for satisfying the goal. The candidates are
those tasks that are retrieved during run time from a repository
of plans and whose enactment is expected to lead to the goal’s
achievement. Once the user has chosen one of the candidate tasks
the task is enacted and after it is completed the goal’s successCon-
dition and abortCondition are checked again for completion or abor-
tion of the goal. If the goal remains InProgress then the process
is repeated.
Our idea of using a combination of state transition system and
Boolean functions to formally deﬁning a framework’s semantic is
now totally new. For instance PROforma and Asbru use similar
state transition machines. In the case of Asbru an additional state
has been considered to suspend a task, which allows stopping
the task’s enactment until its execution can be reassumed contin-
uing from the point it was suspended. In both PROforma and Asbru
the use of Boolean functions to start, abort and complete the enact-
ment of a keystone resembles the interpretation adopted by our
framework.
3.1.3. Goal
As in Fox et al. [9] and Asbru goals represent temporal patterns
which are not satisﬁed but could be achieved in the future, or need
to bemaintained for some period of time or indeﬁnitely. In contrast
with Asbru and Fox et al. work, action-based goals have been ruled
out. Here we only consider state-based goals. The achievement of
state-based goals can be checked based on repositories of clinical
knowledge (drug databases, disease related information, etc.),
and information related to the patient’s medical records and exe-
cution context (health organization’s resource availability).
The framework allows linking goals at run-time with recom-
mended tasks that could satisfy the goals, and it provides an exe-
cution environment for the chosen tasks. But the framework is
not provided with a decision support system to advice on the selec-
tion of tasks.
3.1.4. Task
The tasks that can be chosen to achieve a goal can be of the
following types: a decision on what to believe or what to do (e.g.
decide patient’s diagnosis or treatment), an information enquiry
(e.g. obtain data from patient’s medical record), an action (e.g. pre-
scribe a drug), or a plan as a workﬂow comprising activities and
goals (e.g. plan to decrease blood pressure by prescribing drugs
and exercise).
Tasks can change the workﬂow state (including the ﬂow of con-
trol in the workﬂow and the state of the environment) when en-
acted. Each type of task can have its own attributes. For instance,
decisions have the attribute candidates corresponding to a list of
propositions called beliefs which apply to the decision. In the case
of a diagnostic decision, the candidates are all the possible diagno-
ses. The attribute arguments is a list of arguments in favor of (pro)
or against (con) for each of the candidates. A decision support sys-
tem can suggest the best candidates for the decision by evaluating
the arguments for and against each candidate. Once a clinician has
chosen a candidate he is committed to the corresponding chosen-
Candidate, which in general decides the next care path in the work-
ﬂow enactment. For example, based on the performed tests and
examinations arguments are presented to support different diag-
noses, and after the clinician has chosen a candidate he commits
to the selected diagnosis and therefore he follows a speciﬁc care
path which is conditioned on that choice.3.1.5. Scheduling constraints
The framework is provided with following scheduling con-
straints: sequential composition, XORSplit, ORSplit, ANDSplit,
XORJoin, ORJoin and ANDJoin. The XOR constraint indicates a un-
ique selection, OR constraint indicates that at least one carepath
is selected and AND constraint that all the involved carepaths are
selected.
3.1.6. Actor, role
Goals and tasks can be associated with actors and roles. Roles
are classes of actors who are allowed to take responsibility for exe-
cuting the keystone. The actual actor is the person or system
responsible for performing the keystone, which must belong to
the classes deﬁned in roles. For example, if radiologist is in the
set of roles for performing the keystone, then John who is a radiol-
ogist can enact the keystone.
The framework [8] has been proposed as a workﬂow-based ap-
proach to modeling CIGs. Our experience using the framework for
modeling and enacting prototypical medical scenarios showed that
there was room for incorporating some extensions that would en-
hance the framework’s ﬂexibility. In the next section we explain
the proposed extensions in detail.
3.2. Towards more ﬂexible goal-based workﬂow enactment
In order to further increase the ﬂexibility of the theoretical
framework explained in Section 3.1, we extended it by: (1) consid-
ering more expressive speciﬁcation of actors, roles and actor con-
straints, (2) adding the notions of patient and healthcare
organizations (3) adding an argumentation-based decision support
system for advising clinicians at decision points concerning choices
on what to believe and what to do.
While Fig. 2 depicts the UML class diagram of the extended
framework, below we informally explain each of the proposed
extensions.
3.2.1. Actor, role
In the framework explained in Section 3.1 it was possible to
indicate the roles allowed to perform a keystone and the actual ac-
tor enacting it at run-time. In contrast the approach introduced
here allows more complex speciﬁcation of roles and actors that
could be used during the decision process that leads to the selec-
tion of plans to achieve active goals. This type of information could
be access to determine who is the most suitable health provider to
perform a speciﬁc care plan.
For each actor it is possible to know:
 the health organization the actor is working at;
 a list of actor’s skills, for instance John has a general practitioner
degree (has_skill contains (gp_degree, true)), and
 roles the actor is allowed to play.
For each role it is possible to specify:
 the skills required for performing a role. For instance for playing
the role of clinician the required skill is to have a degree as a
general practitioner (requires contains (gp_degree=true)). There-
fore it is possible to check that John can perform the role of
clinician.
So in our model a keystone contains references to:
(1) the class actor which indicates who is the actor enacting the
keystone;
Fig. 2. UML class diagram depicting the classes and their relationships in the proposed framework.
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who can perform the keystone, for instance by specifying
the set of allowed roles or the set of required skills. For
example as part of a life style change the patient can be sub-
ject of a plan to lose weight, which can be in charge of a cli-
nician, or a nutritionist, or other health professional from the
health organization staff who has a degree or study in nutri-
tion. This can be speciﬁed as actor_constraint= (contains(get-
ActorRoles(),clinician) or contains(getActortRoles(),nutritionist)
or contains(getActorSkills(), studied_nutrition). For instance
nurse Juana has a degree in nutrition, ((studied_nutri-
tion,true) is part of Juana’s skills) because she trained as a
nutrition educator, therefore she can be responsible for the
patient’s weight loss plan;
(3) the patient for whom the keystone is being enacted, and
(4) the health organization where the keystone is being enacted.
3.2.2. Patient, health organization
While in the framework explained in Section 3.1 the concepts of
patient and health organization were implicit in the workﬂow, here
we made them explicit. So now more detailed information about
the patient and the health organization can be speciﬁed for its later
use during the decision process, improving the provided advice.
For this purpose we have introduced a patient class that encap-
sulates the patient’s medical history. This information is vital for
tailoring the workﬂow enactment to the patient’s medical condi-
tion. For instance the target blood pressure in the hypertension
treatment directly depends on the patient’s recent blood pressure
and associated conditions. If according to the medical record the
patient has diabetes and chronic kidney disease then the blood
pressure (BP) goal is less than 130/80 mm Hg, otherwise the BP
goal is less than 140/90 mm Hg.We have also introduced a health organization class that
encapsulates information related to the organization’s resources.
For instance if a treatment is temporarily unavailable in the
organization due to unavailability of a certain medical device the
decision aid should advise to get the treatment from another
organization within the health network if it can be ascertained
that all the resources required to provide the treatment are
available there.3.2.3. Decision support system based on argumentation logic
The framework described in Section 3.1 is not provided with
any decision support system but it assumes that a decision aid
can be plugged into suggest at run-time the best task to achieve
a goal. For this prototype, as in the Tallis engine (http://
archive.cossac.org/tallis/index.html) used to enact PROforma
guidelines, we have chosen an argumentation-based decision sup-
port system. We have implemented a decision support system
that advises the clinician at decision points when there are
choices between alternative beliefs or alternative actions or
goals.
In our argumentation-based decision support system argu-
ments are reasons to believe (in some decision point) or reasons
to act (to achieve a goal). While in classic logic we cannot infer
both a proposition and its negation, in argumentation logic we
can have different arguments simultaneously supporting or oppos-
ing the same proposition. This is very suitable in complex domains
such as medicine where knowledge can be inconsistent. Further-
more, arguments can have relative strengths, which provide a very
human-like approach to reasoning. For a more extensive reading
on argumentation-based inference and decision making in medical
context we refer the reader to [18].
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< name; claim; grounds; qualifier; support;precondition > where :Name: is a string that uniquely identiﬁes the argument.
Claim: is a belief or a plan to achieve a goal, depending on the
type of argument.
Ground: is a set of reasons that explain the argument, in our
case knowledge extracted from the medical knowledge base.
Qualiﬁer: gives the polarity of the argument. Here we have con-
sidered non-conclusive arguments for (pro), against (con) a
claim. We have also considered conclusive conﬁrming (conf)
and excluding (excl) arguments.
Support: is a positive integer between 1 and 100 that gives a
level of support or conﬁdence on the argument. The higher the
number, the higher the level of conﬁdence. Non-conclusive
arguments can have a level of support from 1 to 99, while con-
clusive arguments always have level of support 100. There is no
general consensus of how to weight an argument’s support, the
weight may represent the likelihood that a certain outcome is
achieved (In 30% of the drug is effective reducing blood pres-
sure), the quality of evidence (prospective studies show that this
drug treatment should be preferred over the others to reduce
blood pressure), a combination of quality of evidence and likeli-
hood that an outcome is achieved (based on randomized trials a
drug treatment has proved to be 30% more effective on reducing
blood pressure that the other available options), etc.
Precondition: is a proposition that must be satisﬁed in order to
instantiate the argument.
We have considered three different types of arguments, that
share the same form explained above: argument schemes, action
arguments and belief arguments.
 ActionArgument and BeliefArgument: Action arguments and
belief arguments are used in decisions concerning ‘‘what to
do’’ and ‘‘what to believe’’, respectively. The argument’s claim
is, respectively, a plan for achieving a goal or a belief (expressed
in propositional logic) on which a decision can be based. During
plan execution when a goal or decision task becomes
inProgress, all available libraries are checked to ﬁnd the set
of candidate plans or candidate beliefs that match it. Besides
clinical knowledge, the repository or arguments and argument
schemes are consulted. Argument schemes are checked to ﬁnd
out if it is possible to synthetize pertinent ActionArguments or
BeliefArguments.
For instance when the goal of readjusting the drug hypertension
treatment (goal achieve_prescribe_drugs) becomes active different
actionArguments are available to advice the clinician about possible
treatments to follow for the patient. Or when a clinician has to
achieve thegoal of overcoming thepatient’s hypertensionhehasdif-
ferent hypothesis to explain why the patient is not reacting to the
prescribed treatments. In this case different BeliefArguments based
on the patient medical record and medical evidence can suggest
the reasons for the patient’s resistance to hypertension treatment.
 ArgScheme argument schemes are abstract templates for the
run-time synthesis of action arguments and belief arguments.
For instance we can deﬁne the following scheme for synthesis
of action arguments, with high support based on randomized
controlled trials:<argument_for_thiazide_diuretics_alone_or_combined, candidate,
‘‘thiazide-type diuretics should be used as initial therapy for most
patients, either alone or in combination with one of the other
classes (ACEIs, ARBs, BBs, CCBs) that have been shown to reduceone or more hypertensive complications in randomized con-
trolled outcome trials’’, for, 80, prescriptions=null and con-
tains(outcome(candidate, drug)) and is_thiazide_type_diuretic
(drug)>
At run-time when the goal achieve_prescribe_drugs is inPro-
gress, libraries of plans (provided by the health organization
and by other health organizations within the same network) are
queried to ﬁnd plans that can be used to achieve this goal. For in-
stance the plan Plan_prescribe_metolazone_and_benazepril that sug-
gests metolazone in combination with benazepril could be used to
achieve this goal, because the goal achieve_prescribe_drugs is in-
cluded in the set of the plan’s goalstoAchieve. This plan is supported
by the above argument scheme because metolazone is a type of
thiazide diuretic and benazeptril is a type of ACEI: is_thia-
zide_type_diuretic(metolazone) and outcome(plan_prescribe_Metola-
zone_and_Benazepril)=(Metolazone, Benazepril) can be found in the
medical knowledge.
Then it is possible to instantiate the scheme argument_for_thia-
zide_diuretics_alone_or_combined with Plan_prescribe_metolazone_
and_benazepril and synthesize a concrete ActionArgument.
Coming back to the description of our decision support system,
while candidates with better evidence supporting them are usually
favored over candidates with lower support, the grade of evidence
is not the only factor that inﬂuences the strength of the recommen-
dation represented by a candidate. Some candidates are recom-
mended above others despite the fact that no clinical trial has
been conducted to evaluate the success of different candidates.
For example, surgery to remove operable cancer can be conclu-
sively recommended even though the grade of evidence is weak
because it was never tested in a controlled trial against no surgery
(as the consequences of no surgery are too risky to consider a trial).
To reﬂect this in our decision support system if a claim is sup-
ported by a conclusive conﬁrming (excluding) argument the belief
or plan that constitutes the claim should be chosen, independently
of the evidence support. But when there is no conclusive argument
involved a decision should be taken from a collection of non-con-
clusive arguments. In order to draw conclusions from a collection
of arguments for competing claims we have deﬁned a simple
aggregation function to automatically choose and suggest the
argument with the strongest case. For each claim our aggregation
function consists of: ﬁrstly adding the support of all the supporting
(pro) arguments divided by the number of supporting arguments,
secondly adding the support of all the attacking (con) arguments
divided by the number of opposing arguments, and ﬁnally sub-
tracting the latter from the former.
Finally the claim with the highest support is automatically sug-
gested to the clinician. In the case of a goal, where the clinician
chooses a plan, he commits to it and the chosen plan gets enacted.
In the case of a decision, where the clinician chooses a belief, he
commits to it and based on his choice a subworkﬂow that was con-
ditioned on this choice is enacted.
4. Results
4.1. COGENT implementation of the engine
We have implemented the framework of Section 3.2 in the CO-
GENT system. COGENT is a modeling environment that provides an
integrated approach to model development, description and evalu-
ation of cognitive models. The language is based on the computa-
tional concept of object-orientation and it provides a sound
modeling tool in which models may be evaluated through method-
ologically rigorous computational experiments. COGENT provides
the user with a graphical environment which allows intuitive def-
inition of models. It provides a context for modeling, simulating
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concerns.
COGENT provides a range of basic building blocks from which
our prototype has been constructed:
Ontology: this COGENT module constitutes a hierarchical
knowledge base that contains ontologies of classes. Classes are ar-
ranged in a hierarchical fashion, by virtue of each class’s parent
class. Class inclusion relations and inheritance of attributes operate
over this hierarchy. In COGENT structured knowledge bases are
storage devices that provide special functionality for accessing
and/or structuring knowledge. Their access features allow them
to be used to provide a global ‘‘blackboard’’. We have used this
module to specify the UML class diagram depicted in Fig. 2 and
informally explained in Section 3.2.
Beliefs: this COGENT module is a type of propositional memory
buffer. In COGENT a buffer is an information store, a place where
information can be put for later retrieval. In propositional buffers
elements are symbolic propositions. We have used this buffer as
both a short and long term storage. Examples of short term storage
in the Beliefs buffer are the following: the list of candidates for a
decision or goal, the numeric support for each considered candi-
date after ﬁnding/constructing arguments for/against each candi-
date, and the argument to which the clinician commits. In the
case of long term storage we have used this buffer to save medical
knowledge (related to drug, treatment, diagnosis, etc.) which could
be used at run time to synthesize arguments from schemes. For in-
stance the Beliefs buffer can be used to store information related to
the cost or quantitative measurement of effectiveness of drug
treatments.
Engine: this is a rule-based process that manipulates informa-
tion from the Ontology and the Beliefs according to production-like
rules. Each rule consists of a set of conditions and a set of actions.
Conditions include logical operations whose outcome may be true
or false. Actions result in messages of various forms being sent to
the Ontology or Beliefs components. On each processing cycle, all
the rules whose conditions are satisﬁed are ﬁred in parallel.
We have used the Engine to implement (1) the state-based tran-
sition system (Fig. 1) on which our model is based on, (2) the dy-
namic selection of belief candidates for decisions and action
candidates for goals, (3) the dynamic creation of action and belief
candidates from schemes in the Ontology and knowledge in the Be-
liefs buffer, (4) the aggregation function explained in Section 3.2.3
which allows to compute at run-time the best candidate to achieve
a goal or to commit to a belief.
For example Fig. 3 shows a COGENT rule speciﬁcation in the En-
gine. This rule creates the list of plan candidates for an active goal.
The condition on the rule is that:
(1) according to the Ontology the goal is inProgress;
(2) in the Ontology the goal’s successCondition and abortCondi-
tion are not satisﬁed, and in the Ontology the goal’s invariant-
Condition is satisﬁed;
(3) according to the Beliefmodule no argument or candidate list
has been computed, no candidate has been chosen, the clini-
cian has not committed to any candidate;
(4) a non-empty list of candidate plans can be created by select-
ing from the Ontology all the plans whose (a) goalToAchieve
attribute contains the goal and (b) precondition is satisﬁed;
(5) a non-empty list of candidate plans can be created from the
schemes by selecting from the Ontology all the plans that
fulﬁll the following requirements: (a) satisfy the scheme’s
precondition, (b) its goalToAchieve attribute contains the
goal, and (c) its precondition is satisﬁed.
The rule’s action (which is carried out if the condition is satis-
ﬁed) comprises temporarily adding to the Belief buffer the list ofcandidate plans for the active goal. The candidate list results from
combining the lists of candidates created in (4) and (5).
4.2. Framework evaluation: hypertension guideline
The example presented here has been implemented in the
developed COGENT prototype based on recommendations con-
cerning the treatment of patients with hypertension [10]. We
chose the hypertension guideline because it explicitly deﬁnes the
medical goals and advises on possible treatments to achieve those
goals based on the patient’s condition and the health organization’s
resources. Not all available guidelines deﬁne their goals explicitly
and when they do not some additional preliminary work is re-
quired to identify the implicit medical goals.
Our approach assumes a centralized plan library that might be
authored by the relevant governing organization, like the National
Guideline Clearinghouse (http://www.guideline.gov/) sponsored
by the US Agency for Healthcare Research and Quality. Typically,
each plan in the library will be a collection of goals connected with
scheduling constraints, abstracting away from the details of how
these goals must be achieved. At a local level (say at a particular
health organization) we would expect another plan library with
more concrete plans, deﬁning speciﬁc local plans for achieving
more abstract goals. It can also be the case that some health orga-
nizations are provided with special facilities (medical equipment,
trained staff, etc.) and therefore can provide medical treatments
that other health organizations cannot provide. In this case the
health organizations with the special facilities should make public
a library of the services that they can provide to other health
organizations.
4.2.1. Strategy to quantify and aggregate medical evidence
The hypertension guideline is provided with the following
scheme for classifying the evidence that supports the medical
recommendations:
 Meta-analysis (M): use of statistical methods to combine the
results from clinical trials.
 Randomized controlled trials (RA): also known as experimental
studies.
 Retrospective analyzes (RE): also known as case-control studies.
 Prospective studies (F): also known as cohort studies, including
historical or prospective followup studies.
 Cross-sectional surveys (X): also known as prevalence studies.
 Previous review (PR) or position statements.
 Clinical non-randomized interventions (C).
 General consensus (consensus).
We have assigned to each type of medical recommendations a
numeric value, which will be later used to calculate the support
of the arguments and schemes in the proposed decision support
system: (M, 90) (RA, 80) (RE, 70) (F, 60) (X, 50) (PR, 40) (C, 30) (con-
sensus, 20).
If a candidate has more than one (non) supporting medical rec-
ommendation we aggregate those results as explained in Section
3.2.3. For instance if a candidate plan is supported by 2 M studies
and attacked by a PR study and a consensus opinion then the
aggregation is computed as: (90 + 90)/2  (40 + 20))/2 = 60.
4.2.2. Mapping of hypertension clinical goals into the framework
The hypertension guideline states: ‘‘The ultimate public health
goal of antihypertensive therapy is to reduce cardiovascular and
renal morbidity and mortality. [. . .] Treating [systolic blood pres-
sure] SBP and [diastolic blood pressure] DBP to targets that are
<140/90 mm Hg is associated with a decrease in [cardiovascular
disease] CVD complications. In patients with hypertension and
1)
2)
3)
4)
5)
Fig. 3. COGENT rule for listing the candidate plans for a goal in progress.
Plan_for_reducing_
cardiovascular_renal_
morbidity_and_
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eled this with the plan plan_for_HP_guideline depicted in Fig. 4. This
plan is the responsibility of a primary care clinician (plan’s
actor_constraint is deﬁned as contains(getRoles(),clinician)) and it
becomes active when the patient has high blood pressure, is alive
and has not decided to quit the treatment (precondition = ((sbp >
140 and dbp > 90) or [(sbp > 130 and dbp > 80) and (has_diabetes or
has_renal_disease)]) and alive and not(stop_treatment)). The plan is
aborted when the patient dies or decides to stop the treatment
( abortCondition = stop_treatment or not(alive)). Once the plan
plan_for_HP_guideline gets inProgress the goal maintain_reduc-
tion_cardiovascular_renal_morbidity_and_mortality becomes inPro-
gress. This goal shares the same precondition and abortCondition
with plan_for_HP_guideline.
According to the guideline ‘‘The major goal of management of
both the metabolic syndrome and overweight and obesity is to
reduce the age-related rate of weight gain’’. So to lower blood pres-
sure life style modiﬁcations are advised, in addition to pharmaco-
logic treatment. Between the life style modiﬁcations the following
goals are suggested: reduce weight, adopt DASH eating plan,
reduce dietary sodium, increase physical activity, moderate alcoholPlan_for_HP_
guideline
Begin
maintain_
reduction_
cardiovascular_
renal_morbidity_
and_
mortality
End
Fig. 4. Graphical representation of the initial plan for enacting the hypertension
guideline. Blue hexagons correspond to goals. (For interpretation of the references
to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)consumption, stop smoking, etc. Therefore we have considered as a
candidate plan for the goal maintain_reduction_cardiovascu-
lar_renal_morbidity_and_mortality (Fig. 4) the plan plan_for_reduc-
ing_cardiovascular_renal_morbidity_and_mortality (Fig. 5), which is
also the responsibility of a primary care clinician. The plan starts
with a data query called assessment to access the patient’s medical
record. As denoted by the OrSplit scheduling constraint one or both
carepaths can be taken in parallel: (1) activate the goal of achieving
life style changes, and (2) achieve pharmacologic treatment.
The ﬁrst carepath is activated when the patient has high blood
pressure, the patient is overweight or has cardiovascular risk and
smokes, or consumes more than 2 alcoholic drinks per day and is
a man, or consumes more than 1 alcoholic drink per day and is a
woman, or when the patient’s diet should be improved. All this is
speciﬁed as the precondition of goal achieve_life_style_changes.
The second carepath is activated when the patient has high
blood pressure. The guideline contains a range of evidence-basedmortality
Begin
Achieve_life_
style_changes
Achieve_
pharmacologic_
treatment
EndOr Orassessment
Fig. 5. Graphical representation of the candidate plan for the goal maintain_reduc-
tion_cardiovascular_renal_morbidity_and_mortality. The green diamond corresponds
to an enquiry. Green triangles correspond to Join scheduling constraints, in this case
an AndJoin scheduling constraint. (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the web version of this article.).
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tion of drugs to achieve the patient’s BP goal, and later to maintain
the BP goal. The recommendations are based on the patient’s med-
ical record (like compelling indications or past reactions to hyper-
tension drug treatment) and drug cost-effectiveness studies.
As the guideline states: ‘‘Once antihypertensive drug therapy is
initiated, most patients should return for follow up and adjustment
of medications at monthly intervals or until the BP goal is reached’’.
But during the treatment patients can develop a resistant hyper-
tension, which is deﬁned as ‘‘the failure to achieve goal BP in
patients who are adhering to full doses of an appropriate three-
drug regimen that includes a diuretic’’. For addressing the recom-
mendations on drug treatment and management of hypertension
resistance we have deﬁned the plan plan_for_HP_drug_treatment
(Fig. 6) as candidate for the goal achieve_pharmacologic_treatment
(Fig. 5). As shown in Fig. 6 initially a query called assessment is
performed to request the patient’s medical records. After that, as
indicated by the XorSplit scheduling constraint, a choice has to be
made: (1) if the patient has high BP and a diagnosis of hyperten-
sion resistance then the goal achieve_overcome_hypertension_resis-
tance becomes active, or (2) if the patient does not have a diagnosis
of hypertension resistance and has high BP then the goal achieve_
low_BP is activated. Both (1 and 2) cannot be simultaneously
satisﬁed.
4.3. Guideline enactment for a concrete scenario
We can consider the scenario corresponding to patient Mrs.
Smith who has being recently assessed as a stage 1 hypertension
patient with a SBP = 150 and DBP = 95, has no compelling indica-
tions, but she cannot be prescribed diuretics because they are
not compatible with other treatments she is receiving.
4.3.1. Advice tailoring based on resource availability: service
delegation
In the case of the goal achieve_life_style_changes (Fig. 5), the goal
may be the responsibility of the clinician but could also be taken on
by a more specialized health professional if the health organization
can provide one.
A specialized health professional may be a nutritionist or a
member of the health organization with some degree or study in
nutrition (goal’s actor_constraint is speciﬁed as contains(getActor-
Roles(),clinician) or contains(getActorSkills(),studied_nutrition). For
instance nurse Juana has a degree in nutrition ((studied_nutrition,
true) is one of Juana’s skills) because she trained as a nutrition edu-
cator, so she can be in charge of the achievement of this goal.
Additionally each health organization can differ in the facilities
and resources provided to educate the patient and to implement
and monitor patient’s adherence to life style modiﬁcations. Here
we envision that more variation will be found in the way health
organizations achieve guideline conformance, given that the guide-
line is very ﬂexible and vague on the ways this goal can be
achieved. In the worst case the health organization does notFig. 6. Graphical representation of the candidate plaprovide any resource for helping patients to achieve life style
changes (ownCandidateList = null). When this happens our frame-
work allows service delegation to another health provider within
the health organization’s network. To ﬁnd out if another organiza-
tion provides this service the decision support system will check,
besides the health organization’s library of candidate plans, the li-
braries of services provided by other medical institutions. The ob-
tained information will be presented as arguments during the
decision process.
To support the arguments that advise delegation of a goal to an-
other health institution the decision support system may use
external quality and trust rankings or the own health organiza-
tion’s ranking based on previous experiences of collaboration with
the health institution. For example the following argument may be
generated:
<DelegationArg, Plan_delegate(achieve_life_style_changes), ‘‘The
health center C has a very good reputation on improving life style
in hypertension patients, and past collaborations with the health
organization have been very satisfactory’’, pro, 70, con-
tains(Library_external_services, (achieve_life_style_changes, C))
and ownCandidateList=null>
As we explained in [19] in a delegation the client (in this case
the health organization where the patient is being treated for
hypertension) retains accountability for the service’s outcome
(the goal achieve_life_style_changes) while the provider (health
center C) is responsible for providing the service. In Fig. 7 we show
the goal-based plan that the health organization responsible for
the patient’s hypertension treatment can use to delegate the goal
achieve_life_style_changes to the health center C. The parameter-
ized plan Plan_delegate(achieve_life_style_changes) from Fig. 7 has
been explained in detail in [19] and is basically as follows: once
there is an agreement between provider and client on the re-
quested service (goal achieve_contract_awarded) the service is for-
mally requested (achieve_serv_requested). After that the client can
periodically check the progress of the requested service (main-
tain_delegation_supervised) until the service is completed and the
outcome notiﬁed (achieve_outcome_checked).
4.3.2. Advice on ‘‘what to do’’ tailored to patient’s medical record
For Mrs. Smith the decision support system suggests, as the
guideline does, initial drug treatments based on ACEIs, CCBs, ARBs
and BBs or a combination of both. The clinician chooses a ﬁxed
dose combination of generic ACEI and CCB drugs. His choice is sup-
ported by ActionArguments generated from instantiating
ArgumentSchemes.
From the ArgumentScheme that supports the prescription of
treatments based on ACEI drugs (based on two PR studies and
two M studies) the following ActionArgument is created:
<Scheme_ACEI _drug_treatment_plan, ﬁxed_dose_combined_
generic_ACEIs_and_CCBs_plan, ‘‘The Heart Outcomes prevention
Evaluation study and the European Trial on Reduction of Cardiac
Events with Perindopril in Stable Coronary Artery Disease studyn for the goal achieve_pharmacologic_treatment.
Fig. 7. Plan for delegating the goal achieve_life_style_changes to a heath provider outside the health organization.
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hypertension’’, pro, 65, contains(outcome(ﬁxed_dose_combined_
generic_ACEIs_and_CCBs_plan), drug) and is_ACEIs_type(drug)
and not(ACEI_violates_compeling_indications)>
From the ArgumentScheme that supports the prescription of
treatments based on CCB drugs (supported by RA evidence) the fol-
lowing ActionArgument is created:
<Scheme_CCBs__drug_treatment_plan, ﬁxed_dose_combined_
generic_ACEIs_and_CCBs_plan, ‘‘The European Trial on Systolic
Hypertension in the Elderly showed signiﬁcant reductions in stroke
and all CVD with CCB, as compared with placebo’’, pro, 80, contains
(outcome (ﬁxed_dose_combined_generic_ACEIs_and_CCBs_plan),
drug) and is_CCBs_type(drug) and not(CCBs_ violates_compeling_
indications)>
From the ArgumentScheme that supports the prescription of
ﬁxed doses treatments (based on general consensus) the following
ActionArgument is created:
<Scheme_ ﬁxed_dose_combine_drug_treatment_plan,ﬁxed_dose_
combined_generic_ACEIs_and_CCBs_plan,’’From consensus the use
of ﬁxed-dose combinations may be more convenient and simplify
the treatment regimen and many cost less than the individual
components prescribed separately’’, pro, 20, is_ﬁxed_dose_combi-
nation(outcome (ﬁxed_dose_combined_generic_ACEIs_and_CCBs_
plan)) and cost(outcome(ﬁxed_dose_combined_generic_ACEIs_and_
CCBs_plan))<cost(ﬁrstDrug(outcome (ﬁxed_dose_combined_generic_
ACEIs_and_CCBs_plan)))+ cost(secondDrug(outcome (ﬁxed_dose_
combined_generic_ACEIs_and_CCBs_plan))) >
From the ArgumentScheme that supports the prescription of
generic drugs (based on general consensus) the following ActionAr-
gument is created:
<Scheme_generic_combination_drug_treatment_plan, ﬁxed_dose_
combined_generic_ACEIs_and_CCBs_plan,’’From consensus the use
of generic drugs should be considered to reduce prescription costs,
and the cost of separate prescription of multiple drugs available
generically may be less than non-generic, ﬁxed-dose combina-
tions’’, pro, 20, is_ﬁxed_dose_combination(outcome(ﬁxed_dose_
combined_generic_ACEIs_and_CCBs_plan)) and is_generic(ﬁrst-
Drug(outcome(ﬁxed_dose_combined_generic_ACEIs_and_CCBs_
plan))) andis_generic(secondDrug(outcome(ﬁxed_dose_combined_
generic_ACEIs_and_CCBs_plan))) andcost(ﬁrstDrug(outcome(ﬁxed_
dose_combined_generic_ACEIs_and_CCBs_plan)))+ cost(second-
Drug(outcome(ﬁxed_dose_combined_generic_ACEIs_and_CCBs_
plan)))<cheapest_non_generic_ﬁxed_dose_ACEIs_and_CCBs_
combination>
Thiazide based drug treatments that prescribe thiazide or a
combination of thiazide with other drug (ACEIs, ARBs, BBs or CCBs)
cannot be suggested to Mrs. Smith, because the preconditions of
the supporting ActionArguments and ArgumentSchemes include
not(diuretic_contraindication).If Mrs. Smith had compelling indications (heart failure, post-
myocardial infarction, high coronary disease risk, diabetes, chronic
kidney disease, recurrent strokes) then speciﬁc recommendations
covered by the guideline should apply. For instance if she had
chronic kidney disease then the decision support system should
recommend, as the guideline does, drug treatments combining an
ACEI drug and an ARB drug. Then the clinician can choose a
ﬁxed-dose combination of a non-generic ACEI drug and a non-gen-
eric ARB drug. The chosen candidate plan will be supported by
ActionArguments generated from the following schema:
(1) Scheme_ACEI _drug_treatment_plan and Scheme_ﬁxed_dose_
combine_drug_treatment_plan, as explained above;
(2) ArgumentScheme that supports the prescription of treat-
ments based on ARB drugs for patients with kidney disease.
Because generic drugs are preferred over non-generic drugs an
action argument synthetized from the argument schema Scheme_
generic_combination_drug_treatment_planwill oppose theclinician’s
choice of a non-generic drug treatment. But because there are
enough supportive arguments the clinician’s choice is still a highly
recommended treatment.4.3.3. Re-planning on the ﬂy based on patient’s reaction to treatment
It may be the case that after the initial drug prescription Mrs.
Smith is followed up and her drug treatment is changed multiple
times (different candidate plans are chosen for goal achieve_
low_BP) but she cannot reach the target BP. After multiple drug
prescriptions the clinician can assess her as a case of hypertension
resistance.
In this scenario the goal achieve_low_BP (Fig. 6) fails (abortCon-
dition = hypertension_resistance or not(alive) or stop_treatment)
when the clinician decides that Mrs. Smith has developed hyper-
tension resistance, leading to the abortion of the plan
plan_for_HP_drug_treatment. Because the goal achieve_pharmaco-
logic_treatment from the plan plan_for_reducing_cardiovascu-
lar_renal_morbidity_and_mortality (Fig. 5) is still active and its
abort condition is not satisﬁed ( abortCondition = not(alive) or
stop_treatment) the plan plan_for_HP_drug_treatment (Fig. 6) is
activated again. But this time the goal achieve_overcome_hyperten-
sion_resistance is activated, instead of the goal achieve_low_BP, be-
cause the precondition of the goal achieve_overcome_hypertension_
resistance is satisﬁed (precondition = alive and high_BP and hyperten-
sion_resistance and not(stop_treatment)). In the case of the goal
achieve_low_BP is not activated because there is an XorSplit
scheduling constraint and because it’s precondition is not
satisﬁed ( precondition = high_BP and not(hypertension_resistant)
and not(stop_ treatment) and alive).
According to the guideline once hypertension resistance has
been diagnosed the goal is to identify and correct any remediable
causes, but if this goal fails then the goal is to search for a cause
of secondary hypertension. If the problem still persists then
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Therefore a good candidate plan for the goal achieve_over-
come_hypertension_resistance (Fig. 6) is the plan plan_for_overcom-
ing_hypertension_resistance depicted in Fig. 8. Initially, as part of
the plan_for_overcoming_hypertension_resistance, a query called
assessment is made to request patient’s medical records, and then
as the XorSplit scheduling constraints indicate it only one of the
following goals is chosen:
(1) achieve_correct_remediable_causes,
(2) achieve_correct_secondary_causes, or
(3) achieve_refer_to_specialist.
The ﬁrst two goals succeed when the target blood pressure is
achieved (SuccessCondition = not (has_high_BP)) after ﬁnding and
treating the cause for hypertension resistance.
The ﬁrst two goals fail when the patient’s BP is high and there
are no more candidate plans to achieve these goals (abortCondi-
tion = has_high_BP and ownCandidateList = null).
The last goal succeeds when the health organization has a
hypertension specialist available or when the patient can be re-
ferred to a hypertension specialist from another health organiza-
tion. The third goal fails when the clinician cannot refer the
patient to any hypertension specialist in the health organization
or other health organizations from the collaborating network.
4.3.4. Advice on ‘‘what to believe’’
In our scenario when Mrs. Smith develops a resistance to the
hypertension treatment the clinician should try to ﬁnd the reasons
for the resistance and activate a corrective plan. Therefore as part
of the Plan_for_correcting_remediable_causes (Fig. 9) after asking
the patient some questions and performing some medical tests
the decision Diagnosis_hypertension_resistant is activated. In the
case of Mrs. Smith the decision support system suggests that the
resistance is caused by volume overload based on the following
BeliefArguments:
<Belief_volume_overload_from_sodium_intake, Diagnosis_vol-
ume_overload, ‘‘excess sodium intake’’, pro, 80, has_high_
sodium_intake>
<Belief_volume_overload_from_kidney_disease, Diagnosis_vol-
ume_overload, ‘‘high volume water retention from kidney disease’’,
pro, 80, has_kidney_disease and has_symptoms_ﬂuid_retention>
Therefore the clinician commits to the belief that the patient
could be suffering from volume overload (candidate belief Diagno-
sis_volume_overload) and he readjusts the drug treatment (goal
achieve_adjust_drug_treatment) to attempt to lower the patient’s
blood pressure.
When the patient’s BP is lowered the goal achieve_correct_reme-
diable_cause (Fig. 8) is achieved (SuccessCondition = not(has_high_Plan_for_overcoming_
hypertension_resistance
Begin
Achieve_
correct_
remediable_
causes
Achieve_
correct_
secondary_
causes
EndXor Xor
Assessment
resistance
Achieve_
refer_to_
specialist
Fig. 8. Candidate plan for the goal achieve_overcome_hypertension_resistance.BP)), the plan plan_for_overcoming_hypertension_resistance is com-
pleted and the goal achieve_overcome_hypertension_resistance from
plan plan_for_HP_drug_treatment (Fig. 6) is achieved (SuccessCon-
dition = not(has_high_BP)). Next in the plan plan_for_HP_drug_treat-
ment the goal maintain_low_BP becomes active. This goal consists
on periodically following up the patient’s BP, checking if the target
BP is maintained.
If the goalmaintain_low_BP fails because the patient has high BP
the plan plan_for_HP_drug_treatment gets discarded, but if the goal
achieve_pharmacologic_treatment (Fig. 5) is still active (abortCondi-
tion is not satisﬁed) then plan HP_drug_treatment_plan becomes ac-
tive again and the goal achieve_low_BP is reactivated.
If the patient dies or decides to ﬁnish treatment all the goals
and plans are automatically discarded. For instance the goal main-
tain_low_BP (Fig. 6) is discarded if the patient dies, or decides to
quit the treatment, or the BP is higher than the goal standard
(abortCondition = not(alive) or stop_treatment or has_high_BP).5. Lessons learned from the prototype evaluation with multiple
guidelines
In contrast with the hypertension guideline [10] explained
above, some medical guidelines are explained as task-based ﬂows
and clinical goals remain implicit. Therefore initially we evaluated
the COGENT prototype with medical recommendations from a
medical guideline that used task-based ﬂows to communicate best
medical practices. We chose the part of a chronic cough guideline
[12] corresponding to recommendations for inmunocompetent
adult patients. After discovering the goal-based clinical guideline
speciﬁcation that was implicit in [12] we showed that the resulting
goal-based guideline produced a decision support system that
yields the same recommendations as the task-based guideline.
Mapping the task-based guideline [12] into a goal-based guidelines
not only made explicit the hidden clinical goals, but also exposed:
(1) medical evidence implicit in the scheduling constrains of the
task-ﬂow (For young nonsmoker performing a Chest X-ray
can be skipped. The medical evidence states that the proba-
bility of PNDS/Asthma/GERD is higher than the average pop-
ulation, therefore it is more cost-effective and less time
consuming to skip Chest X-ray);
(2) values or selective criteria (for the previous example skip-
ping Chest X-ray maximizes cost-effectiveness).
We also evaluated the COGENT prototype with recommenda-
tions from the NICE breast cancer guideline for breast cancer
[11]. Similarly to the hypertension scenario explained here the
framework showed ﬂexibility and adaptability in:5.1. Advising and tailoring health care based on a health organization’s
resources and a patient’s particular medical condition
For the treatment of early breast cancer various options are
available: mastectomy with axillary clearance, lumpectomy with
axillary clearance, mastectomy with sentinel lymph node (SLN)
biopsy, lumpectomy with SLN biopsy, adjuvant chemotherapy,
adjuvant endocrine, and reexcision. But the options available for
the patient depend on her medical record (for instance reexcision
is only offered if the patient had lumpectomy before), and the hos-
pital resources (while all the treatment options are offered by UK
National Health System (NHS), not all the options are available in
the hospital where the patient is treated). Therefore our decision
aid informed, based on the patient’s medical record and the hospi-
tal’s resources, which treatment options where available in the
hospital or in other NHS hospitals.
Fig. 9. Candidate plan for the goal achieve_correct_remediable_cause. The pink rounded shape corresponds to a decision. The precondition of the goal
achieve_adjust_drug_treatment is that the chosen candidate for the decision is the diagnosis of drug-induced hypertension resistance, the precondition of the goal
achieve_improve_volume_overload is that the chosen candidate is the diagnosis of volume overload, and the precondition of the goal achieve_resolve_associated_conditions is
that the chosen diagnosis corresponds to associated conditions (obesity, excess alcohol intake). (For interpretation of the references to colour in this ﬁgure legend, the reader
is referred to the web version of this article.)
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examples of this sort in Sections 4.3.1 and 4.3.2.
5.2. Delegating health care based on resource availability or quality of
care
For instance for some treatment options, like SLN biopsy sur-
gery, not all the NHS hospitals have the required clinical staff (sur-
geon specialized in breast surgeries) and therefore the patient care
has to be delegated to other hospital. In the case of the hyperten-
sion guideline we provided a concrete example of this type in Sec-
tion 4.3.1.
5.3. Replanning when unexpected situations arise
For instance the patient was being treated for breast cancer, but
after receiving chemotherapy treatment she develops metastasis
and the disease stage is no more an early breast cancer. Therefore
the new clinician’s goal is to treat the patient’ advanced cancer. In
the case of the hypertension guideline we provided a concrete
example of replanning on the ﬂy in Section 4.3.1.
We found out that the three medical guidelines considered for
the prototype evaluation provided different scheme for classifying
the evidence that supported their medical recommendations. But
for the three different evidence scheme considered in guidelines
[10–12], mapping the medical evidence into argument’s support
was straightforward. See for instance in Section 4.2.1 how we
mapped the evidence scheme provided by the hypertension guide-
line [10] into arguments’ support.
6. Discussion: related approaches
If we have to compare our approach with available languages
for the speciﬁcation and enactment of medical guidelines, then
we could do it in terms of the same criteria used for measuring
the ﬂexibility and adaptability of our framework:
6.1. Advising and tailoring health care based on patient’s medical
conditions and organization’s resources
Our formalism provides mechanisms to facilitate the speciﬁca-
tion of information related to actor, roles, health organizations and
patient’s medical records. This information could be used to
dynamically select at run-time the best available treatment based
on the patient’s medical conditions, the health organizations’facilities and the available medical staff. But according to [1] in
the available languages for the enactment of clinical guidelines is
it possible to specify decision aid based on switch constructs, argu-
mentations schema, decision trees, calls to external functions and
inﬂuence diagrams. Therefore we assume that, the same as we
did here, the available languages could be extended with more de-
tailed information related to actor, roles, health organizations and
patient’s medical records. This information could be used, as we
showed in this paper, to advice and tailor the healthcare based
on patient’s medical conditions and organization’s resources. For
instance in the case of EON, PRODIGY and GLIF they are provided
with very complex patient information models to inﬂuence the
process decision. In the case of PROforma, Asbru, and Grando
et al. [8] it is currently possible to indicate the preferred actor or
role who is responsible for the enactment of a task or goal, though
no additional information on the actor’s and roles’ skills and re-
sources is directly supported in those languages.6.2. Delegating health care based on resource availability or quality of
care
Originally the enactment of CIGs was considered a centralized
task. But there have been a few recent attempts to distribute the
enactment of CIGs between different health providers, mainly
based on multi-agent systems [8] [6], service-oriented architec-
tures [14] and distributed process enactment [5,15]. In the case
of the GLARE [20] formalism, it has been extended in [21] with
an application-independent methodology to support human inter-
action and human resources coordination for the distributed
enactment of clinical guidelines. Their approach is based on asso-
ciating to task the notion of context (where the action can be exe-
cuted), role (who can execute the action) and competences (actor’s
skills).
The above mentioned approaches share a similar strategy for
distribution based on design-time role-based process speciﬁca-
tions that are assigned at run-time to concrete actors (health orga-
nizations, humans, information-based systems, autonomous
agents, etc.) for their enactment. The mechanisms used for the
run-time selection of the actors are mainly based on matching
the actor’s skills speciﬁcation with the role’s requirements. In the
case of multiple actors offering similar services more sophisticated
mechanism of selection based on trust have been used [5] in the
distributed enactment of PROforma. Coordination and data sharing
between actors can be achieved through the exchange of message
via communication channels.
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time matching of actor’s skills with roles. But it differs on assuming
goal-based speciﬁcations instead of task-based workﬂow deﬁni-
tions. Based on this difference our framework can provide the fol-
lowing features for enhancing ﬂexibility:
 communication as an implementation issue that does not need
to be speciﬁed at design-time but can freely emerge at run-time
(see for instance in Section 4.3.1 the example of service delega-
tion), and
 optional use of a decision support system for advising on the
selection of the most suitable service provider for achieving
active goals.
6.3. Replanning when unexpected situations arise
In our framework goals provide an intuitive way to replan based
on: (re)activating a goal if its precondition is satisﬁed, checking the
goal’s successCondition to determine if the goal was achieved after
the chosen care plan was completed, selecting a new plan if the
previously selected plan was completed and the goal was not
achieved, and aborting a goal if its abortcondition is satisﬁed. In
the case of task-based languages something similar can be
achieved by providing Boolean functions to control plan execution.
Like ﬁlter, setup, suspend, reactivate, complete and abort expres-
sions in Asbru; or precondition, iteration condition, termination
condition, and abort condition in PROforma.
7. Conclusions, future work
In this paper we propose a way to implement ﬂexible goal-
based plan specialization taking advantage of an argumentation-
based decision model to separate decision-relevant knowledge
from plan speciﬁcations.
Our approach allows: (a) compliance to medical recommenda-
tions while tailoring the care plan to the health organization’s local
resources and patient’s response to treatment; (b) monitoring and
manipulating signiﬁcant clinical goals that are normally implicit in
clinical guidelines rather than modeling guidelines as procedural
plans and (c) delegating/assigning treatments to other health orga-
nizations when the local provider’s resources are not the most
appropriate for the patient’s medical condition.
Besides the hypertension guideline explained in Section 4.2 we
have implemented in the COGENT prototype recommendations
from a chronic cough guideline [12] for immune-competent adult
patients, and also recommendations from a NICE guideline for
early breast cancer [11].
One restriction of our prototype is that does not allow assigning
priorities to goals. We are considering as future work the possibil-
ity of adding priorities to the goal and replacing the argumenta-
tion-based decision support system proposed here with a multi-
criteria decision support system that will help the patient and
the clinician to make choices involving several goals with different
levels of priority. Possible candidates are value-based methods that
lead the decision maker(s) through a series of judgments that pro-
duce quantitative scores or rankings over relative priorities of the
decision criteria. For instance how important is effectiveness over
cost, or cost over side effects. Methods in this category include
ordinal weighting methods, direct weighting, methods based on
multiatribute utility theory, and the Analytic Hierarchy Process.
For a review of these methodologies we refer the reader to [22].
We are currently working on replacing our prototype with a
tool speciﬁed in a more scalable programming language thanCOGENT. For the new tool we will use Protégé to specify the ontol-
ogies and Java to implement the engine. Besides we will use the
Semantic Web Rule Language (SWRL) [23] and the Jess reasoner
(http://www.jessrules.com/links/) for deﬁning and evaluating the
Boolean conditions such as: conditions that restrict the workﬂow
enactment (precondition, postcondition, etc.), arguments, argu-
ment schemes, and the rules that enact the goal-based engine
and the argumentation-based decision support. Protégé, Java, and
SWRL are well developed and mature languages which have suc-
cessfully been used in numerous real applications, so we are very
conﬁdent of achieving the scalability, reusability and interoperabil-
ity that we are aiming.References
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